VPS39 and neoplasm: In B16F10 tumor-bearing Jα18-/- chimeric mice (Figure 3E), CD45.2+Vam6+/- iNKT cells displayed higher level of mTORC1 activation (Figure 3F) and lower level of AMPK activation (Figure 3G) than CD45.1+ Vam6+/+ iNKT cells after α-GC injection.